Skip to main content

TEVA 7032 Pill - orange capsule/oblong

Pill with imprint TEVA 7032 is Orange, Capsule/Oblong and has been identified as Mycophenolic Acid Delayed-Release 360 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Mycophenolic acid is used in the treatment of Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7032

Mycophenolic acid delayed-release 360 mg TEVA 7032

Mycophenolic Acid Delayed-Release

TEVA 7032
360 mg
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7032 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.